Bling Capital
1439 Royal Ann Ct, San Jose, California, 95129, United States
Overview
Bling Capital is a venture capital investment firm based in the San Francisco Bay Area, California. It primarily invests in consumer tech, internet, mobile, marketplace, data, fintech, SaaS, and automation sectors.
- Total investments
- 109
- Lead investments
- 26
- Investments · 12mo
- 19
- Active investors
- 8
Sector focus
- Finance
- Financial Services
- Impact Investing
- Marketplace
- Venture Capital
Investment portfolio
- ShipIn
Participated · Series B · Aug 2026
ShipIn provides an AI-driven operational intelligence platform for commercial shipping, converting onboard vessel data into actionable insights to improve safety, productivity, and performance. Its platform is deployed by over 90 shipowners across more than 1,300 vessels. The company raised $52 million to expand its AI platform and accelerate growth as the industry adopts more data-driven operations. Investors in the round include Proofpoint Capital, HighSage Ventures, Bling Capital, Framework Venture Partners, Tokio Marine HCC's Future Fund, Zeev Ventures, Munich Re, Atinc, Hyperplane, and Two Lanterns Venture Capital. Two Lanterns has been an investor since ShipIn’s Seed round. The company is led by Osher Perry, who was highlighted in the announcement.
- HaloBraid
Participated · Seed · Jun 2026
HaloBraid develops a robotic braiding assistant that allows a stylist to start a braid and hand off the remainder of the process to the device, which can finish braids in seconds. The company’s first product is designed to be gentle on textured hair and to handle styles such as knotless and box braids, with a planned launch later this year. HaloBraid was founded by Yinka Ogunbiyi and has a team of about 15 people; it raised a $7M seed round led by Seven Seven Six. In customer research of 2,000 people the company found 95% said they would get braided more often if it took less time, and it estimates people spend roughly 8 billion hours braiding hair each year. The startup faces few direct competitors in the automated-braider space (notably Braidiant) and is already considering additional devices such as a tool to undo braids.
- Maneva
Participated · Series A · Jun 2026
Maneva builds a data and control layer for manufacturing that leverages proprietary physical AI and vision-language models to convert existing camera infrastructure into real-time operational intelligence. Its models, VITA and ALIS, run on NVIDIA edge devices and integrate with sensors and equipment signals to detect safety issues, bottlenecks and inefficiencies, diagnose root causes, and trigger automated responses across machinery, workflows and teams. The company serves customers across confectionery, wood, glass, steel, meat processing, food and beverage, pharmaceuticals, cosmetics and distribution sectors. Maneva plans to expand globally and roll out factory orchestration features and AI knowledge agents using proceeds from its Series A. The company has raised $38.4m in total capital to date and is led by CEO Rae Jeong and CTO Kelvin Chan.
- Reaxiomatic
Participated · Seed · Jun 2026
Reaxiomatic was founded by Skyler Shuford, who previously co‑founded Hermeus. The company positions itself to refresh critical defense platforms. It has just completed a $7.25 million pre‑seed raise co‑led by Scout Ventures with a group of participating investors. Reaxiomatic is immediately hiring a small team of engineers and operators in San Diego to begin work. Public reporting does not disclose revenues, users, or other operating metrics at this time.
- Novellia
Participated · Series A · Jun 2026
Novellia provides an AI-powered platform that helps patients find and unify up to 20 years of medical data from disparate hospital systems, doctors' offices, and labs in seconds. Its technology applies proprietary NLP models to extract signals from unstructured clinical text—such as physician notes, lab narratives, and diagnostic reports—and produces anonymized, harmonized datasets for research. Novellia says its customers include several of the top 10 pharmaceutical companies as well as early-stage diagnostics companies, and it has signed seven-figure, multi-year contracts with major pharma. The company recently launched a patient-facing mobile app as an extension of its online platform. Novellia has received industry recognition and awards and is backed by peer-reviewed research presented at medical congresses. Financially, the company has raised $28 million in total funding following the announced $18 million Series A.